Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes

Journal of Autoimmunity

Volumn 39, Issue 4, 2012, Pages 466-470

  Arentz, Georgia ^a   Thurgood, Lauren A ^a   Lindop, Rhianna ^a   Chataway, Tim K ^b   Gordon, Tom P ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Mass spectrometry; Primary Sj gren's syndrome; Public clonotypes; Ro52 (TRIM21)

Indexed keywords

AUTOANTIBODY; HUMAN RO52 AUTOANTIBODY; IMMUNOGLOBULIN G1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAVY CHAIN; HUMAN; LIGHT CHAIN; MALE; MASS SPECTROMETRY; POLYMYOSITIS; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNITY; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN KAPPA-CHAINS; ISOELECTRIC FOCUSING; MALE; MASS SPECTROMETRY; MIDDLE AGED; PEPTIDES; PROTEOME; RIBONUCLEOPROTEINS; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME;

EID: 84869887947     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.07.003     Document Type: Article

References (22)

1. Rhodes D.A., Ihrke G., Reinicke A.T., Malcherek G., Towey M., Isenberg D.A., et al. The 52000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-g inducible tripartite motif protein associated with membrane proximal structures. Immunology 2002, 106:246-256.
2. Rhodes D.A., Trowsdale J. TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol Immunol 2007, 44:2406-2414.
3. Ben-Chetrit E., Chan E.K., Sullivan K.F., Tan E.M. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 1988, 161:1560-1571.
4. Chan E.K., Hamel J.C., Buyon J.P., Tan E.M. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991, 87:68-76.
5. Schulte-Pelkum J., Fritzler M., Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 2009, 8:632-637.
6. Dugar M., Cox S., Limaye V., Gordon T.P., Roberts-Thomson P.J. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity. Postgrad Med J 2010, 86:79-82.
7. Ghillani P., André C., Toly C., Rouquette A.M., Bengoufa D., Nicaise P., et al. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentre study. Autoimmun Rev 2011, 10:509-513.
8. Lindop R., Arentz G., Thurgood L.A., Reed J.H., Jackson M.W., Gordon T.P. Pathogenicity and proteomic signatures of autoantibodies to Ro and La. Immunol Cell Biol 2012, 90:304-309.
9. Salomonsson S., Sonesson S.E., Ottosson L., Muhallab S., Olsson T., Sunnerhagen M., et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005, 201:11-17.
10. Karnabi E., Boutjdir M. Role of calcium channels in congenital heart block. Scand J Immunol 2010, 72:226-234.
11. Wada K., Kamitani T. Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem Biophys Res Commun 2006, 339:415-421.
12. James L.C., Keeble A.H., Khan Z., Rhodes D.A., Trowsdale J. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci USA 2007, 104:6200-6205.
13. McEwan W.A., Mallergy D.L., Rhodes D.A., Trousdale J., James L.C. Intracellular antibody-mediated immunity and the role of TRIM21. Bioessays 2011, 33:803-809.
14. Espinosa A., Dardalhon V., Brauner S., Ambrosi A., Higgs R., Quintana F.J., et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 2009, 206:1661-1671.
15. Yang K., Shi H.X., Liu X.Y., Shan Y.F., Wei B., Chen S., et al. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 2009, 182:3782-3792.
16. Elagib K.E., Tengnér P., Levi M., Jonsson R., Thompson K.M., Natvig J.B., et al. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kD in primary Sjögren's syndrome. Arthritis Rheum 1999, 42:2471-2481.
17. Salomonsson S., Ottosson L., Säfsten P., Hof D., Brauner H., Sunnerhagen M., et al. Cloning and characterisation of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block. J Autoimmunity 2004, 22:167-177.
18. Mietzner B., Tsuiji M., Scheid J., Velinzon K., Tiller T., Abraham K., et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from non-reactive and polyreactive precursors. Proc Natl Acad Sci USA 2008, 105:9727-9732.
19. Lindop R., Arentz G., Chataway T.K., Thurgood L.A., Jackson M.W., Reed J.H., et al. Molecular signatures of a public clonotypic autoantibody in primary Sjögren's syndrome. Arthritis Rheum 2011, 63:3477-4386.
20. VanDuijn M.M., Decker L.J., Zeneyedpour L., Smitt P.A., Luider T.M. Immune responses are characterised by specific shared immunoglobulin peptides that can be detected by proteomic techniques. J Biol Chem 2010, 285:29,247-29,253.
21. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
22. Ottosson L., Hennig J., Espinosa A., Brauner S., Wahren-Herlenius M., Sunnerhagen M. Structural, functional and immunologic characterisation of folded subdomains in the Ro52 protein targeted in Sjögren's syndrome. Mol Immunol 2006, 43:588-598.